Detalles de la búsqueda
1.
Membrane-based therapeutic plasma exchange: Hemodynamics and operational characteristics leading to procedure failure.
J Clin Apher;
36(6): 841-848, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34486748
2.
New onset diabetes with ketoacidosis following nivolumab immunotherapy: A case report and review of literature.
J Oncol Pharm Pract;
27(3): 716-721, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32723064
3.
Clinical Outcomes With Pembrolizumab-Based Therapies in Recurrent/Refractory NSCLC After Chemoradiation and Consolidative Durvalumab.
Clin Lung Cancer;
24(6): e205-e213, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37188597
4.
Vepafestinib is a pharmacologically advanced RET-selective inhibitor with high CNS penetration and inhibitory activity against RET solvent front mutations.
Nat Cancer;
4(9): 1345-1361, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37743366
5.
Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC.
Cancer Discov;
13(7): 1556-1571, 2023 07 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37068173
6.
Novel patient-derived models of desmoplastic small round cell tumor confirm a targetable dependency on ERBB signaling.
Dis Model Mech;
15(1)2022 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34841430
7.
Primary central nervous system diffuse large B-cell lymphoma masqueraded as Bing-Neel syndrome: Steps in management and review of future directions.
Clin Case Rep;
9(12): e05113, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34925831
8.
Novel Preclinical Patient-Derived Lung Cancer Models Reveal Inhibition of HER3 and MTOR Signaling as Therapeutic Strategies for NRG1 Fusion-Positive Cancers.
J Thorac Oncol;
16(7): 1149-1165, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33839363
9.
The Anti-HER3 mAb Seribantumab Effectively Inhibits Growth of Patient-Derived and Isogenic Cell Line and Xenograft Models with Oncogenic NRG1 Fusions.
Clin Cancer Res;
27(11): 3154-3166, 2021 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33824166
10.
MET Exon 14-altered Lung Cancers and MET Inhibitor Resistance.
Clin Cancer Res;
27(3): 799-806, 2021 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33172896
11.
Primary Bone Lymphoma: A Case Series and Review of Literature.
Case Rep Hematol;
2020: 4254803, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32328322
12.
Primary central nervous system marginal zone B-cell lymphoma arising from the dural meninges: A case report and review of literature.
Clin Case Rep;
8(3): 491-497, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-32185043
13.
RET inhibition in novel patient-derived models of RET-fusion positive lung adenocarcinoma reveals a role for MYC upregulation.
Dis Model Mech;
2020 Dec 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-33318047
14.
A Case of Immunotherapy-Induced Colitis Complicated by Perforation and Treated with Infliximab Postoperatively.
Case Rep Oncol Med;
2019: 9069354, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31428491
15.
Can Radiomics Bridge the Gap Between Immunotherapy and Precision Medicine in Lung Cancer?
J Thorac Oncol;
18(6): 686-688, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37210178
16.
Response to ERBB3-Directed Targeted Therapy in NRG1-Rearranged Cancers.
Cancer Discov;
8(6): 686-695, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29610121
17.
Author Correction: Vepafestinib is a pharmacologically advanced RET-selective inhibitor with high CNS penetration and inhibitory activity against RET solvent front mutations.
Nat Cancer;
4(10): 1526, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37814012
Resultados
1 -
17
de 17
1
Próxima >
>>